Objective:
The goal was to establish the role of intravenous hydration therapy on mild bronchiolitis.
Methods:
This was a retrospective case control study. Infants between 1 month and 2 years of age admitted to our general pediatrics ward between June 2012 and June 2013 with a diagnosis of uncomplicated acute bronchiolitis were enrolled to the study. Hospital medical files were reviewed to get information about children personal history, symptoms of the disease, disease severity scores and their management. Patients were classified into 4 groups according to the management; nebulized short-acting β2-agonist (salbutamol) +hydration; nebulized short-acting β2-agonist (salbutamol); hydration and neither bronchodilator nor hydration. We examined length of stay in the hospital as an outcome measure.
Results:
A total of 94 infants were studied. There was no significant difference between groups in terms of length of stay in hospital.
Conclusions:
IV hydration is not effective on length of stay in hospital in mild acute bronchiolitis patients.
SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries
